Modulation of lymphokine-activated killer cell-mediated cytotoxicity by estradiol and tamoxifen

International Journal of Cancer

Volumn 66, Issue 2, 1996, Pages 214-218

  Baral, Edward ^a   Nagy, Eva ^a   Berczi, Istvan ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CYCLOHEXIMIDE; DACTINOMYCIN; ESTRADIOL; HORMONE RECEPTOR; INTERLEUKIN 2; TAMOXIFEN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FEMALE; LYMPHOKINE ACTIVATED KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; KILLER CELLS, LYMPHOKINE-ACTIVATED; RATS; RATS, INBRED F344; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0029884364     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960410)66:2<214::AID-IJC13>3.0.CO;2-C     Document Type: Article

References (22)

1. ARENDS, M.J. and WYLLIE, A.H., Apoptosis: mechanisms and roles in pathology. Int. Rev. exp. Pathol., 32, 223-254 (1991).
2. BARAL, E., GLAS, U., RUTQUIST, L.E. and SKOOG, L., Adjuvant therapy in postmenopausal patients with operable breast cancer. In: Fundamental Problems in Breast Cancer, p. 335, M. Nijhoff, Amsterdam (1987).
3. BARAL, E., NAGY, E. and BERCZI, I., Tamoxifen as an immunomodulatory agent. In: I. Berczi and J. Szelenyi (eds.), Advances in psychoneuroimmunology, pp. 233-241, Plenum Press, New York (1994a).
4. BARAL, E., NAGY, E. and BERCZI, I., Target cells are sensitized for cytotoxic T-lymphocyte-mediated destruction by estradiol and tamoxifen. Int. J. Cancer, 57, 1-5 (1994b).
5. BARAL, E., NAGY, E. and BERCZI, I., Enhancement of natural killer cell mediated cytotoxicity by tamoxifen. Cancer, 75, 591-599 (1995).
6. BARAL, E., NAGY, E. and BERCZI, I., The effect of tamoxifen on the immune response. In: J.A. Kellen (ed.), Tamoxifen: beyond the antiestrogen, Birkhauser, Boston (1996) (In press).
7. BARAL, E. and VANKY, F., Effect of tamoxifen on cell-mediated autotumor lysis. J. clin. Lab. Immunol., 22, 97-100 (1987).
8. COHEN, J.H.N., DANEL, L., CORDIER, G., SAEZ, S. and REVILLARD, J.P., Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8 positive cells. J. Immunol., 131, 2767-2771 (1983).
9. DOHERTY, P.C., Cell-mediated cytotoxicity. Cell, 75, 607-612 (1993).
10. DUNN, T.B. and POTTER, J.A., A transplantable mast cell neoplasm in the mouse. J. nat. Cancer Inst., 18, 587-601 (1957).
11. EORTC BREAST CO-OPERATIVE GROUP, Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second EORTC Workshop. Europ. J. Cancer, 16, 1513-1515 (1980).
12. JORDAN, V.C., ALLEN, K.E. and DIX, C.J., Pharmacology of tamoxifen in laboratory animals. Cancer Treat. Rep., 64, 745-759 (1980).
13. KOLBER, M.A., Human cytotoxic T lymphocytes and activated peripheral blood lymphocytes enhance cytochalasin B-induced DNA fragmentation of indicator bystander cells. Cell. Immunol., 139, 208-217 (1992).
14. LERNER, L.J. and JORDAN, V.C., Development of antiestrogens and their use in breast cancer: 8th Cain memorial award lecture. Cancer Res., 50, 4177-4189 (1990).
15. MANDEVILLE, R., GHALI, S.S. and CHAUSSEAU, J.-P., In vitro stimulation of human NK activity by an estrogen antagonist (tamoxifen) Europ. J. Cancer clin. Oncol., 20, 983-985 (1984).
16. NAGY, E. and BERCZI, I., Immunomodulation by tamoxifen and pergolide. Immunopharmacology, 12, 145-153 (1986).
17. PICHON, M.F. and MILGROM, E., Characterization and assay of progesterone receptor in human mammary carcinoma. Cancer Res., 37, 464-471 (1977).
18. ROSENBERG, S.A., LOTZE, M.T., MUUL, L.M., CHANG, A.E., AVIS, F.P., LEITMAN, S., LINEHAN, W.M., ROBERTSON, C.N., LEE, R.E. and RUBIN, J.T., A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin 2 or high-dose interleukin 2 alone. New Engl. J. Med., 316, 889-897 (1987).
19. Ross, G.T., VAN DE WIELE, R.L. and FRANTZ, A.G., The ovaries. In: R.H. Williams (ed ), Textbook of endocrinology (6th ed.), p. 355, W.B. Saunders, Philadelphia (1981).
20. SABBADINI, E., Studies on the mechanism of target cell lysis induced by immune cells. J. Reticuloendothel. Soc., 7, 551-566 (1970).
21. STIMSON, W.H., Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scand. J. Immunol., 28, 345-350 (1988).
22. ZYCHLINSKY, A., ZHENG, L.M., LIU, C.C. and YOUNG, J.D., Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J. Immunol., 146, 393-400 (1991).